BACK TO FUNDAMENTALS

Jaysynth Orgochem Ltd. - Quarterly/Annual Result Disclosures and Notes dated 30 Jun 2023

Auditor and Management Disclosures and Notes for the quarterly results dated 30 Jun 2023

1. The Un-audited Financial Results for the quarter ended 30th June, 2023 have been reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on Tuesday, 08th August, 2023. The Financial results are prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under Section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standards) Rule 2015 (as amended).
2. In accordance with the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Statutory Auditors have performed limited review of the above Un-audited Financial Results for the quarter ended 30th June, 2023.
3. The basic and diluted earnings per share is computed by dividing the Profit / (Loss) after tax attributable to equity shareholders, by the weighted average number of equity shares outstanding during the period/year.
4. The Board of Directors of the Company at its meeting held on Tuesday, 24th January, 2023 had considered and approved the Composite Scheme of Arrangement amongst Jaysynth Dyestuff (India) Limited ("Transferor Company 1"), Jaysynth Impex Private Limited (“Transferor Company 2”) and JD Orgochem Limited ("Transferee Company") and their respective shareholders and creditors, under Section 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme"). The Scheme, inter alia, provides for amalgamation by absorption of Transferor Companies with and into Transferee Company (with effect from Appointed date 01st April, 2023) and in consideration thereof, the Transferee Company shall issue equity shares and preference shares to the shareholders of Transferor Company 1 and Transferor Company 2 respectively. The equity shares shall be listed on Bombay Stock Exchange Limited. The scheme is, inter alia, subject to receipt of the statutory and regulatory approvals, including approvals from stock exchange, National Company Law Tribunal, Mumbai Bench and the shareholders and creditors of the Companies involved in the Scheme and the Company is in the process of seeking the same.
5. The Company has only one Segment.
6. Previous period figures have been regrouped/rearranged wherever required.